CVS HealthNYSE: CVS

CVS Health Corporation (NYSE:CVS) will participate in the Wolfe 2024 Healthcare Results Conference on November 19, 2024, at 10:20 AM ET. Tom Cowhey, the Executive Vice President and Chief Financial Officer, will be present, while Justin Lake from Wolfe Research will also join the call. Justin acknowledged Larry McGrath, the head of strategy in Investor Relations, for his valuable contributions to the company, even though he chose not to join them on stage.

David Faber from CNBC shares updates about CVS.

On Monday, CVS Health announced that it will add four new members to its board from Glenview Capital Management, a hedge fund that has been advocating for changes at the large healthcare company.

CVS Health made an agreement with the activist investor Glenview Capital, allowing them four seats on the board. Glenview had been advocating for changes within the healthcare company and had discussions with the previous CEO, Karen Lynch, before she was removed.

CVS Health Corp (NYSE:CVS) saw a rise in pre-market trading after revealing that it has added four new board members due to an agreement with activist investor Glenview Capital Management. Larry Robbins, the CEO of the hedge fund, will be joining the board along with Leslie Norwalk, Guy Sansone, and Doug Shulman, bringing the total number of directors to 16.

On Monday, CVS Health announced that it will welcome four new members to its board as part of a deal with Glenview Capital Management, which includes the hedge fund's CEO, Larry Robbins.

CVS Health's Board of Directors has added four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman. These appointments come after successful talks with Glenview Capital Management. The announcement was made on November 18, 2024, in Woonsocket, Rhode Island.

Three major investment companies believe that CVS Health, which is struggling, will see changes soon. They increased their current investments and also started a new one in the third quarter, as shown in regulatory documents.

Users of Zacks.com have been paying a lot of attention to CVS Health (CVS) lately. Therefore, it's important to understand the key information that could influence the stock's future.